Lars Sävendahl, MD, PhD

Professor
Karolinska Institutet
Stockholm, Stockholms Lan, Sweden

Disclosure information not submitted.

Presentation(s):

• SAT-202 - Long-term risk of neoplastic events in patients with Turner syndrome treated with growth hormone during childhood

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SUN-027 - An Exploratory Assessment of the Globe-Reg Registry for Studying the Safety of Long-Acting Growth Hormone in Cancer Survivors (the SAFE-Survivors Study)

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT